Subscribe To
EVOK / Evoke Pharma (EVOK) Stock: 1-For-12 Reverse Split Goes Into Effect
EVOK News
By Seeking Alpha
March 21, 2023
Evoke Pharma, Inc. (EVOK) Q4 2022 Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Daniel Kontoh-Boateng - Investor Rel more_horizontal
By Seeking Alpha
November 9, 2022
Evoke Pharma, Inc. (EVOK) Q3 2022 Results - Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK ) Q3 2022 Results Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Daniel Kontoh-Boateng - I more_horizontal
By GlobeNewsWire
September 6, 2022
Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference
SOLANA BEACH, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on tr more_horizontal
By Seeking Alpha
August 10, 2022
Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q2 2022 Results - Earnings Call Transcript
Evoke Pharma, Inc. (NASDAQ:EVOK ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Of more_horizontal
By Pulse2
May 23, 2022
Evoke Pharma (EVOK) Stock: 1-For-12 Reverse Split Goes Into Effect
A 1-for-12 reverse stock split of Evoke Pharma (NASDAQ: EVOK) has gone into effect. These are the details. more_horizontal
By Seeking Alpha
May 10, 2022
Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript
Evoke Pharma, Inc. EVOK Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Q more_horizontal
By Seeking Alpha
March 8, 2022
Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript
Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript more_horizontal